A New Efficient Method for the Total Synthesis of Linear Furocoumarins

Bang-Le Zhang; Fang-Dao Wang; Jian-Min Yue

doi:10.1055/s-2006-926250

LETTER

A New Efficient Method for the Total Synthesis of Linear Furocoumarins

Bang-Le Zhang^a,b, Fang-Dao Wang^a, Jian-Min Yue*^a
^a State Key Laboratory of Drug Research, Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 555 Zuchongzhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, P. R. of China
^b Department of Pharmacology, Fourth Military Medical University, Xi’an Shaanxi 710032, P. R. of China
Fax: +86(21)50806718; e-Mail: jmyue@mail.shcnc.ac.cn;

Abstract

Alle Artikel dieser Rubrik

Abstract

A new efficient method for the synthesis of linear furocoumarins by a Nef reaction and intramolecular cyclocondensation in one pot results in the construction of a benzofuran ring. This method provides a new strategy to furnish the benzofuran framework easily, and also allows the convenient synthesis of furocoumarin derivatives with different substituents on the coumarin ring by a subsequent Pechmann reaction. This strategy has also been applied to the preparation of four additional benzofuran derivatives.

Key words

Nef reaction - Pechmann reaction - furocoumarins - total synthesis - intramolecular cyclocondensation

Volltext

Referenzen

References and Notes

<A NAME="RW08905ST-1">1</A> Bethea D. Fullmer B. Syed S. Seltzer G. Tiano J. Rischko C. Gillespie L. Brown D. Gasparro FP. J. Dermatol. Sci. 1999, 19: 78

<A NAME="RW08905ST-2A">2a</A> Grundmann KM. Ludwig R. Zollner TM. Ochsendorf F. Thaci D. Boehncke WH. Krutmann J. Kaufmann R. Podda M. J. Am. Acad. Dermatol. 2004, 50: 734

<A NAME="RW08905ST-2B">2b</A> Grimes PE. Clin. Dermatol. 1997, 15: 921

<A NAME="RW08905ST-2C">2c</A> Petering H. Breuer C. Herbst R. Kapp A. Werfel T. J. Am. Acad. Dermatol. 2004, 50: 68

<A NAME="RW08905ST-3A">3a</A> Diederen PVMM. Weelden H. Sanders CJG. Toonstra J. Vloten WA. J. Am. Acad. Dermatol. 2003, 48: 215

<A NAME="RW08905ST-3B">3b</A> Miolo G. Tomanin R. Rossi AD. Dall AF. Zacchello F. Scarpa M. J. Photochem. Photobiol. B 1994, 26: 241

<A NAME="RW08905ST-3C">3c</A> Lage C. Pádula M. Alencar TAM. Gonçalves SRF. Vidal LS. Cabral-Neto J. Leitão AC. Mutat. Res. Rev. Mutat. Res. 2003, 544: 143

<A NAME="RW08905ST-4">4</A> Cimino GD. Gamper HB. Isaacs ST. Hearst JE. Ann. Rev. Biochem. 1985, 54: 1151

<A NAME="RW08905ST-5">5</A> Edelson RL. Arch. Dermatol. 1999, 135: 600

<A NAME="RW08905ST-6A">6a</A> Goupil JJ. inventors; French Patent 2:698,270.

<A NAME="RW08905ST-6B">6b</A> Goaster JL. inventors; French Patent 2:691,629.

<A NAME="RW08905ST-7">7</A> Wiesmann A. Weller A. Lischka G. Klingebiel T. Kanz L. Einsele H. Bone Marrow Transplant 1999, 23: 151

<A NAME="RW08905ST-8">8</A> Kaufman KD. Erb DJ. Blok TM. Carlson RW. Knoechel DJ. McBride L. Zeitlow T. J. Heterocycl. Chem. 1982, 19: 1051

<A NAME="RW08905ST-9">9</A> Nore P. Honkanen E. J. Heterocycl. Chem. 1980, 17: 985

<A NAME="RW08905ST-10">10</A> Macleod JK. Worth BR. Tetrahedron Lett. 1972, 237

<A NAME="RW08905ST-11A">11a</A> Esse RC. Christensen BE. J. Org. Chem. 1960, 25: 1565

<A NAME="RW08905ST-11B">11b</A> Abu-Shady H. Hassib ST. Amin KM. Farag AE. Egypt. J. Pharm. Sci. 1990, 31: 453

<A NAME="RW08905ST-12">12</A> Zubia E. Luis FR. Massanet GM. Collado IG. Tetrahedron 1992, 48: 4239

<A NAME="RW08905ST-13A">13a</A> Ahluwalia VK. Prakash C. Bala S. Monatsh. Chem. 1980, 111: 877

<A NAME="RW08905ST-13B">13b</A> Aquila BM. Tetrahedron Lett. 1997, 38: 2795

<A NAME="RW08905ST-14">14</A> Hayakawa K. Yodo M. Ohsuki S. Kanematsu K. J. Am. Chem. Soc. 1984, 106: 6735

<A NAME="RW08905ST-15A">15a</A> Mal D. Bandhyopadhyay M. Datta K. Murty KVSN. Tetrahedron 1998, 54: 7525

<A NAME="RW08905ST-15B">15b</A> Mal D. Murty KVSN. Datta K. Tetrahedron Lett. 1994, 35: 9617

<A NAME="RW08905ST-16">16</A> Herndon JW. Zhang Y. Wang H. Wang K. Tetrahedron Lett. 2000, 41: 8687

<A NAME="RW08905ST-17">17</A> Nicolaou KC. Snyder SA. Bigot A. Pfefferkorn JA. Angew. Chem. Int. Ed. 2000, 39: 1093

<A NAME="RW08905ST-18A">18a</A> Roshchin AI. Kel’chevski SM. Bumagin NA. J. Organomet. Chem. 1998, 560: 163

<A NAME="RW08905ST-18B">18b</A> Youn SW. Eom JI. Org. Lett. 2005, 7: 3355

<A NAME="RW08905ST-19">19</A> Bellur E. Freifeld I. Langer P. Tetrahedron Lett. 2005, 46: 2185

<A NAME="RW08905ST-20">20</A> Tsai T. Wang E. Huang K. Li S. Wang Y. Lin Y. Chen Y. Heterocycles 2004, 63: 1771

<A NAME="RW08905ST-21">21</A> Majumdar KC. Basu PK. Mukhopadhyay PP. Tetrahedron 2005, 61: 10603

<A NAME="RW08905ST-22A">22a</A> Ballini R. Petrini M. Tetrahedron 2004, 60: 1017

<A NAME="RW08905ST-22B">22b</A> Van Tamelen EE. Thiede RJ. J. Am. Chem. Soc. 1952, 74: 2615

<A NAME="RW08905ST-22C">22c</A> Kornblum N. Erickson AS. Kelly WJ. Henggeler B. J. Org. Chem. 1982, 47: 4534

<A NAME="RW08905ST-22D">22d</A> McMurry JE. Melton J. J. Org. Chem. 1973, 38: 4367

<A NAME="RW08905ST-22E">22e</A> Keinan E. Mazur Y. J. Am. Chem. Soc. 1977, 99: 3861

<A NAME="RW08905ST-23">23</A> Dauzonne D. Royer R. Synthesis 1984, 1054

Benzofuran 4: Compound 2 (2 mmol) was added to an aq soln of 2 M NaOH (15 mL) and stirred at r.t. for 30 min under an N₂ atmosphere. After cooling to 0 °C, the resultant solution was added dropwise to a well-stirred aq solution of 3 M H₂SO₄ (25 mL) at 0 °C. The reaction was stirred at r.t. for about 4 h until the reaction was complete. The solution was extracted with EtOAc and the organic phase was dried over anhyd Na₂SO₄. After removal of the solvent, the residue was purified by flash chromatography on silica gel to afford the desired compound 4. [28] Mp 54-55 °C. IR (KBr): 3423, 3122, 1602, 1446, 1132, 837 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.52 (d, J = 2.2 Hz, 1 H), 7.42 (d, J = 8.5 Hz, 1 H), 7.00 (m, 1 H), 6.79 (dd, J = 8.5 Hz, J = 2.2 Hz, 1 H), 6.69 (dd, J = 2.2 Hz, J = 0.9 Hz, 1 H), 5.16 (br s, 1 H). EI-MS: m/z (%) = 134 (M⁺, 100), 105(30), 78 (35), 51 (15). Anal. Calcd for C₈H₆O₂: C, 71.64; H, 4.51. Found: C, 71.57; H, 4.52.

5b-f; General Procedure: To a mixture of 4 and an appropriate β-ketoester (ratio 1:1.2), an excess of MsOH (0.5 mL per mmol of 4) was slowly added, and stirred at 0 °C for 30 min. Stirring was continued at r.t. until the reaction was complete (monitored by TLC). The resulting mixture was poured into ice-water, stirred for 1 h at r.t., extracted with EtOAc, the organic phase was dried over anhyd Na₂SO₄, and then concentrated in vacuo. The residue was purified by flash chromatography over silica gel (PE-acetone) to afford the title compounds 5b-f.
5b Yield: 72%; mp 186-187 °C (acetone) (lit. [29] 185-186 °C). IR (KBr): 3161, 1724, 1631, 1385, 746 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.82 (s, 1 H), 7.69 (d, J = 2.4 Hz, 1 H), 7.48 (d, J = 0.4 Hz, 1 H), 6.86 (dd, J = 2.4 Hz, J = 0.4 Hz, 1 H), 6.27 (s, 1 H), 2.51 (s, 3 H). EI-MS: m/z (%) = 200 (M⁺, 100), 172 (70), 171 (75), 144 (10), 115 (25).
5c Yield: 70%; mp 170-171 °C. IR (KBr): 3122, 2972, 1716, 1629, 1583, 1130 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.86 (s, 1 H), 7.69 (d, J = 2.4 Hz, 1 H), 7.49 (d, J = 0.8 Hz, 1 H), 6.84 (dd, J = 2.4 Hz, J = 0.8 Hz, 1 H), 6.28 (t, J = 1.2 Hz, 1 H), 2.89 (dq, J = 7.2 Hz, J = 1.2 Hz, 2 H), 1.38 (t, J = 7.2 Hz, 3 H). EI-MS: m/z (%) = 214 (M⁺, 75), 185 (30), 171 (100), 115 (15). Anal. Calcd for C₁₃H₁₀O₃: C, 72.89; H, 4.71. Found: C, 72.97; H, 4.65.
5d Yield: 65%; mp 127-128 °C (lit. [30] 128-129 °C). IR (KBr): 3112, 2955, 1708, 1630, 1576, 1161, 1112 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.84 (s, 1 H), 7.68 (d, J = 2.4 Hz, 1 H), 7.47 (s, 1 H), 6.84 (d, J = 2.4 Hz, 1 H), 6.25 (s, 1 H), 2.81 (t, J = 7.6 Hz, 2 H), 1.79 (m, 2 H), 1.08 (t, J = 7.6 Hz, 3 H). EI-MS: m/z (%) = 228 (M⁺, 100), 200(35), 185 (70), 171 (70), 115 (20).
5e Yield: 67%; mp 142-143 °C. IR (KBr): 3101, 1731, 1628, 1581, 1450, 1283, 1151 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.97 (q, J = 1.9 Hz, 1 H), 7.75 (d, J = 2.2 Hz, 1 H), 7.56 (d, J = 0.5 Hz, 1 H), 6.90 (dd, J = 2.2 Hz, J = 0.8 Hz, 1 H), 6.79 (s, 1 H). EI-MS: m/z (%) = 254 (M⁺, 90), 226 (100), 198 (20), 169 (20). Anal. Calcd for C₁₂H₅F₃O₃: C, 56.71; H, 1.98. Found: C, 56.67; H, 2.10.
5f Yield: 58%; mp 177-178 °C. IR (KBr): 3128, 3124, 1722, 1626, 1568, 1375, 1149 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.68 (s, 1 H), 7.67 (br s, 1 H), 7.57-7.47 (m, 6 H), 6.76 (dd, J = 2.2 Hz, J = 1.0 Hz, 1 H), 6.34 (s, 1 H). EI-MS: m/z (%) = 262 (M⁺, 90), 234 (100), 205 (35), 176 (30), 76 (20). Anal. Calcd for C₁₇H₁₀O₃: C, 77.85; H, 3.84. Found: C, 77.94; H, 3.92.

Psoralen 5a: A mixture of ZnCl₂ (210 mg, 1.5 mmol), ethyl propiolate (0.5 mL, 5 mmol), and compound 4 (134 mg, 1.0 mmol) was heated at 90 °C for 3 h under a N₂ atmosphere. After cooling to r.t., 5% HCl (25 mL) was added to the resultant mixture, which was then extracted with EtOAc
(3 × 25 mL). The combined organic layer was washed with H₂O (3 × 10 mL), brine (20 mL), and dried over anhyd Na₂SO₄. The solvent was removed on a rotary evaporator to yield the crude product which was purified by flash chromatography to give the desired compound 5a. Yield: 56%; mp 162-163 °C (lit. [13a] 161-162 °C). IR (KBr): 3157, 1720, 1633, 1286, 1136, 750 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 7.81 (d, J = 9.6 Hz, 1 H), 7.70 (d, J = 1.2 Hz, 1 H), 7.69 (s, 1 H), 7.49 (s, 1 H), 6.84 (d, J = 1.2 Hz, 1 H), 6.39 (d, J = 9.6 Hz, 1 H). EI-MS: m/z (%) = 186 (M⁺, 100), 158 (90), 130 (30), 102 (40).

9a: [31a] ¹H NMR (400 MHz, CDCl₃): δ = 7.62 (d, J = 1.6 Hz, 1 H), 7.57 (d, J = 10.0 Hz, 1 H), 7.51 (d, J = 8.4 Hz, 1 H), 7.30-7.27 (m, 2 H), 6.77 (d, J = 1.6 Hz, 1 H). EI-MS: m/z (%) = 118 (M⁺, 100), 78 (45).
9b: [31b] ¹H NMR (400 MHz, CDCl₃): δ = 7.52 (d, J = 2.4 Hz, 1 H), 7.43 (d, J = 9.1 Hz, 1 H), 7.00 (s, 1 H), 6.81 (d, J = 9.1 Hz, 1 H), 6.69 (d, J = 2.4 Hz, 1 H), 3.78 (s, 3 H). EI-MS: m/z (%) = 148 (M⁺, 100), 134 (25), 78 (15).
9c: [31c] ¹H NMR (400 MHz, CDCl₃): δ = 7.74 (s, 1 H), 7.63 (d, J = 2.3 Hz, 1 H), 7.39 (m, 2 H), 6.73 (d, J = 2.3 Hz, 1 H). EI-MS: m/z (%) = 197 (M⁺, 95), 196 (100), 78 (25).
9d: [31d] ¹H NMR (400 MHz, CDCl₃): δ = 8.16 (d, J = 10.3 Hz, 1 H), 7.95 (d, J = 8.6 Hz, 1 H), 7.86 (d, J = 2.4 Hz, 1 H), 7.42-7.37 (m, 1 H), 6.95 (d, J = 2.4 Hz, 1 H). EI-MS: m/z (%) = 163 (M⁺, 100), 105 (25), 78 (35).

<A NAME="RW08905ST-28">28</A> Coleman PJ. Brashear KM. Askew BC. Hutchinson JH. McVean CA. Duong LT. Feuston BP. Fernandez-Metzler C. Gentile MA. Hartman GD. Kimmel DB. Leu CT. Lipfert L. Merkle K. Pennypacker B. Prueksaritanont T. Rodan GA. Wesolowski GA. Rodan SB. Duggan ME. J. Med. Chem. 2004, 47: 4829

<A NAME="RW08905ST-29">29</A> Chatterjee DK. Chatterje RM. Sen K. J. Org. Chem. 1964, 29: 2467

<A NAME="RW08905ST-30">30</A> Ahluwalia VK. Tripathi RP. J. Indian Chem. Soc. 1984, 61: 1023

<A NAME="RW08905ST-31A">31a</A> Topolski M. J. Org. Chem. 1995, 60: 5588

<A NAME="RW08905ST-31B">31b</A> Okuyama T. Fueno T. Bull. Chem. Soc. Jpn. 1974, 47: 1263

<A NAME="RW08905ST-31C">31c</A> Kelly TR. Szabados A. Lee YJ. J. Org. Chem. 1997, 62: 428

<A NAME="RW08905ST-31D">31d</A> Van Wijngaarden I. Kruse CG. Van der Heyden JAM. Tulp MTM. J. Med. Chem. 1988, 31: 1934